Asthma Drug Shows Promise As Study Continues

This study of a common asthma drug budesonide [Pulmocort] has not yet been peer-reviewed, but the results are extremely promising — 90% reduction of risk of urgent care or hospitalization!

“The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalization by 90% when compared with usual care, Oxford University said.”